Karius

Genomic infectious disease diagnostics

Karius detects microbial cell-free DNA circulating in the bloodstream, using genomics and AI to give physicians diagnostic insight that supports rapid treatment decisions. The advantage is breadth from a single blood draw: conventional infectious disease diagnosis requires guessing at a pathogen and testing for it specifically, often through invasive sampling, which costs days that critically ill patients do not have. The company is expanding the rollout of its proprietary next-generation sequencing test across hospitals and health systems, working to optimise how infectious diseases are diagnosed and treated.